Literature DB >> 29689344

The relationship between interleukin-6 and functional connectivity in methamphetamine users.

Milky Kohno1, Jennifer M Loftis2, Marilyn Huckans3, Laura E Dennis4, Holly McCready4, William F Hoffman5.   

Abstract

Methamphetamine (MA) causes an increase in pro-inflammatory cytokines in animal models and in humans. Resulting activation of microglia and neuro-inflammation could, via effects on reward networks, mediate behavioral characteristics of addiction. We examined the relationship between interleukin-6 (IL-6) and corticolimbic and striatolimbic resting-state functional connectivity (RSFC). Thirty adults diagnosed with MA dependence and 20 control subjects underwent a resting-state functional magnetic resonance imaging (fMRI) scan and gave a blood sample for determination of plasma IL-6 levels. Seed-based RSFC analyses were performed to examine the interactive effect of group and IL-6 on ventral striatal and prefrontal connectivity. Within the MA group, IL-6 levels were positively related to striatolimbic RSFC but negatively related to corticostriatal RSFC. Our findings with IL-6 support the idea that inflammation may at least partly mediate the link among MA use disorder, RSFC, and behavior, possibly via effects on mesolimbic and mesocortical dopaminergic systems. Published by Elsevier B.V.

Entities:  

Keywords:  Corticostriatal; IL-6; Inflammation; Mesocorticolimbic; Methamphetamine; Resting-state functional connectivity

Mesh:

Substances:

Year:  2018        PMID: 29689344      PMCID: PMC5971003          DOI: 10.1016/j.neulet.2018.04.037

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  53 in total

1.  Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior.

Authors:  Krista McFarland; Christopher C Lapish; Peter W Kalivas
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

Review 2.  Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection.

Authors:  Kenneth H Clark; Clayton A Wiley; Charles W Bradberry
Journal:  Neurotox Res       Date:  2012-06-20       Impact factor: 3.911

3.  IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy.

Authors:  Ebrahim Haroon; Bobbi J Woolwine; Xiangchuan Chen; Thaddeus W Pace; Samir Parekh; James R Spivey; Xiaoping P Hu; Andrew H Miller
Journal:  Neuropsychopharmacology       Date:  2014-01-31       Impact factor: 7.853

4.  Cerebral microglia mediate sleep/wake and neuroinflammatory effects of methamphetamine.

Authors:  Jonathan P Wisor; Michelle A Schmidt; William C Clegern
Journal:  Brain Behav Immun       Date:  2011-02-17       Impact factor: 7.217

5.  Methamphetamine causes persistent immune dysregulation: a cross-species, translational report.

Authors:  Jennifer M Loftis; Dongseok Choi; William Hoffman; Marilyn S Huckans
Journal:  Neurotox Res       Date:  2010-10-17       Impact factor: 3.911

6.  Cytokine-induced enhancement of calcium-dependent glutamate release from astrocytes mediated by nitric oxide.

Authors:  Tomoaki Ida; Masayuki Hara; Yoichi Nakamura; Shunji Kozaki; Shigeru Tsunoda; Hideshi Ihara
Journal:  Neurosci Lett       Date:  2007-12-25       Impact factor: 3.046

7.  Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation.

Authors:  David M Thomas; Paul D Walker; Joyce A Benjamins; Timothy J Geddes; Donald M Kuhn
Journal:  J Pharmacol Exp Ther       Date:  2004-05-26       Impact factor: 4.030

8.  Risky decision making, prefrontal cortex, and mesocorticolimbic functional connectivity in methamphetamine dependence.

Authors:  Milky Kohno; Angelica M Morales; Dara G Ghahremani; Gerhard Hellemann; Edythe D London
Journal:  JAMA Psychiatry       Date:  2014-07-01       Impact factor: 21.596

9.  Performance of multiplex cytokine assays in serum and saliva among community-dwelling postmenopausal women.

Authors:  Richard W Browne; Alpdogan Kantarci; Michael J LaMonte; Christopher A Andrews; Kathleen M Hovey; Karen L Falkner; Ali Cekici; Danielle Stephens; Robert J Genco; Frank A Scannapieco; Thomas E Van Dyke; Jean Wactawski-Wende
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

10.  Is there "one" DLPFC in cognitive action control? Evidence for heterogeneity from co-activation-based parcellation.

Authors:  Edna C Cieslik; Karl Zilles; Svenja Caspers; Christian Roski; Tanja S Kellermann; Oliver Jakobs; Robert Langner; Angela R Laird; Peter T Fox; Simon B Eickhoff
Journal:  Cereb Cortex       Date:  2012-08-23       Impact factor: 5.357

View more
  10 in total

Review 1.  Neuroinflammation in addiction: A review of neuroimaging studies and potential immunotherapies.

Authors:  Milky Kohno; Jeanne Link; Laura E Dennis; Holly McCready; Marilyn Huckans; William F Hoffman; Jennifer M Loftis
Journal:  Pharmacol Biochem Behav       Date:  2019-01-26       Impact factor: 3.533

2.  A preliminary randomized clinical trial of naltrexone reduces striatal resting state functional connectivity in people with methamphetamine use disorder.

Authors:  Milky Kohno; Laura E Dennis; Holly McCready; Daniel L Schwartz; William F Hoffman; P Todd Korthuis
Journal:  Drug Alcohol Depend       Date:  2018-09-21       Impact factor: 4.492

3.  Cognition during active methamphetamine use versus remission.

Authors:  Marilyn Huckans; Stephen Boyd; Grant Moncrief; Nathan Hantke; Bethany Winters; Kate Shirley; Emily Sano; Holly McCready; Laura Dennis; Milky Kohno; William Hoffman; Jennifer M Loftis
Journal:  J Clin Exp Neuropsychol       Date:  2021-10-06       Impact factor: 2.283

4.  Functional connectivity abnormalities underlying mood disturbances in male abstinent methamphetamine abusers.

Authors:  Ping Jiang; Jiayu Sun; Xiaobo Zhou; Lu Lu; Lei Li; Xiaoqi Huang; Jing Li; Keith Kendrick; Qiyong Gong
Journal:  Hum Brain Mapp       Date:  2021-05-03       Impact factor: 5.038

5.  Probabilistic Reversal Learning Deficits in Patients With Methamphetamine Use Disorder-A Longitudinal Pilot Study.

Authors:  Maximilian Pilhatsch; Shakoor Pooseh; Alexandra Junke; Milky Kohno; Johannes Petzold; Cathrin Sauer; Michael N Smolka
Journal:  Front Psychiatry       Date:  2020-12-09       Impact factor: 4.157

6.  Brain network dysfunctions in addiction: a meta-analysis of resting-state functional connectivity.

Authors:  Serenella Tolomeo; Rongjun Yu
Journal:  Transl Psychiatry       Date:  2022-01-28       Impact factor: 7.989

7.  Quercetin Mitigates Methamphetamine-Induced Anxiety-Like Behavior Through Ameliorating Mitochondrial Dysfunction and Neuroinflammation.

Authors:  Fengrong Chen; Jiaxue Sun; Cheng Chen; Yongjin Zhang; Lei Zou; Zunyue Zhang; Minghui Chen; Hongjin Wu; Weiwei Tian; Yu Liu; Yu Xu; Huayou Luo; Mei Zhu; Juehua Yu; Qian Wang; Kunhua Wang
Journal:  Front Mol Neurosci       Date:  2022-02-28       Impact factor: 5.639

8.  Psychopathy and Corticostriatal Connectivity: The Link to Criminal Behavior in Methamphetamine Dependence.

Authors:  William F Hoffman; Merel B Jacobs; Laura E Dennis; Holly D McCready; Alex W Hickok; Sheehan B Smith; Milky Kohno
Journal:  Front Psychiatry       Date:  2020-02-28       Impact factor: 4.157

9.  Detection of H3K4me3 Identifies NeuroHIV Signatures, Genomic Effects of Methamphetamine and Addiction Pathways in Postmortem HIV+ Brain Specimens that Are Not Amenable to Transcriptome Analysis.

Authors:  Liana Basova; Alexander Lindsey; Anne Marie McGovern; Ronald J Ellis; Maria Cecilia Garibaldi Marcondes
Journal:  Viruses       Date:  2021-03-24       Impact factor: 5.048

10.  The Relationships between HIV-1 Infection, History of Methamphetamine Use Disorder, and Soluble Biomarkers in Blood and Cerebrospinal Fluid.

Authors:  T Jordan Walter; Jennifer Iudicello; Debra Rosario Cookson; Donald Franklin; Bin Tang; Jared W Young; William Perry; Ronald Ellis; Robert K Heaton; Igor Grant; Arpi Minassian; Scott Letendre
Journal:  Viruses       Date:  2021-07-01       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.